New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
08:17 EDTNPSPNPS Pharmaceuticals sees FY14 net Gattex/Revestive sales $110M-$120M
Sees FY14 operating expenses $180M-$200M.
News For NPSP From The Last 14 Days
Check below for free stories on NPSP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 11, 2014
07:28 EDTNPSPNPS Pharmaceuticals attractive ahead of launch updates, says Leerink
Leerink calls shares of NPS Pharmaceuticals "very attractive" ahead of the Gattex launch updates on the company's Q2 and Q3 earnings conference calls. Leerink says its survey of 34 gastroenterologists who treat 739 short bowel syndrome patients indicated continued robust increases in Gattex uptake during the second half of 2014 and through 2016. It reiterates an Outperform rating on NPS with a $40 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use